IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1384
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$1.4B
Daniel Tassé
DBV Technologies S.A. engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$DBVT DBV Technologies S.A. | 54 | 34 | 45 | 93 | - | - | -250.8% | -120.0% | 100.0% | -2601.5% | -2622.4% | 138.9% | 0.0% | 109.0x | $1.4B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
DBV Technologies S.A. (DBVT) receives a "Hold" rating with a composite score of 54.1/100. It ranks #1384 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Daniel Tassé
Chief Executive Officer
Labor Force
80
34
22
55
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for DBVT
Outperforming peers — winners tend to keep winning over 3-12 months
Fair valuation relative to peers
Weak fundamentals — higher risk of value trap
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for DBVT.
View All RatingsImproving capital utilization rates confirmed
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 34 | 13 | +21ALPHA |
| MOMENTUM | 93 | 97 | -4NEUTRAL |
| VALUATION | 45 | 23 | +22ALPHA |
| INVESTMENT | 22 | 5 | +17ALPHA |
| STABILITY | 55 | 42 | +13ALPHA |
| SHORT INT | 61 | 70 | -9DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -250.8% (sector -2.5%)
GM 100% vs sector 43%, OM -2601% vs sector 1%
Capital turnover N/A, R&D intensity 1678.5%
Rev growth 139%, 10yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns DBV Technologies S.A. a Hold rating, with a composite score of 54.1/100 and 3 out of 5 stars. Ranked #1384 of 7,333 stocks, DBVT presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
DBVT's quality score of 34/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -250.8% (sector avg: -2.5%), gross margins of 100.0% (sector avg: 42.5%), net margins of -2622.4% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 45/100, DBVT appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 22.31x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
DBV Technologies S.A.'s investment score of 22/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 138.9% vs. a sector average of 5.9% and a return on assets of -120.0% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
DBV Technologies S.A. (DBVT) is exhibiting exceptional momentum with a score of 93/100, placing it among the strongest trending stocks in the market. Revenue growth stands at 138.9% year-over-year, while a beta of 0.04 reflects its sensitivity to broader market moves. Stocks with momentum scores this high have historically outperformed over the following 3–12 months, suggesting DBVT may continue to benefit from strong institutional interest and positive price trends.
With a stability score of 55/100, DBVT exhibits average financial resilience. Key stability metrics include a beta of 0.04 and a debt-to-equity ratio of 109.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
DBVT carries a short interest score of 61/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 109.00x), small-cap liquidity risk. At $1.4B market cap (small-cap), DBV Technologies S.A. offers reasonable institutional liquidity.
DBV Technologies S.A. is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1384 of 7,333 overall (81st percentile). Key comparisons include ROE of -250.8% trailing the -2.5% sector median and operating margins of -2601.5% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While DBVT currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Momentum (93) vs Investment (22) — closing this gap could shift the rating.
ROE 10013% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 135% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 201765% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate DBV Technologies S.A. (DBVT) as a Hold with a composite score of 54.1/100 at a current price of $22.19. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in momentum (93th percentile) and stability (55th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (22th percentile) and quality (34th percentile) tempers our overall conviction. We assign a No Moat rating (37/100), High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; sustainability of the current growth rate; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is narrowing, which raises the risk of a future downgrade if the trend persists.
DBV Technologies S.A. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 54.1/100 places it at rank #1384 in our full 7,333-stock universe. At $1.4B in market capitalization, DBV Technologies S.A. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
The near-term outlook is constructive, with revenue growing at 139% and momentum in the 93th percentile confirming positive market sentiment and institutional accumulation. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy. Investment factor at the 22th percentile indicates reinvestment patterns that investors should monitor for sustainability.
The margin cascade tells an important story: gross margins of 100% (+57.5pp vs sector) narrow to operating margins of -2601% (-2602.8pp vs sector) and net margins of -2622.4%, yielding a gross-to-net conversion rate of -2622%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $22.19, DBV Technologies S.A. is trading near fair value based on current fundamentals. Our value factor score of 45/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at P/B of 22.3x, P/S of 194.5x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 100% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 139% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
Positive momentum (93th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
Elevated leverage (109% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -2622.4% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a High uncertainty rating to DBV Technologies S.A.. Key risk factors include significant leverage (109% debt-to-equity), current negative profitability (net margin -2622.4%), weak quality scores (34th percentile). The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: significant leverage (109% debt-to-equity); current negative profitability (net margin -2622.4%); weak quality scores (34th percentile); low beta of 0.04 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 55th percentile and quality factor at the 34th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 100% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate DBV Technologies S.A.'s capital allocation as Poor. Key concerns include low returns on equity (-250.8%), negative profitability, weak asset returns (ROA -120.0%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — DBV Technologies S.A. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, DBV Technologies S.A. receives a Hold rating with a composite score of 54.1/100 (rank #1384 of 7,333). Our quantitative framework assigns a No Moat (37/100, trend: narrowing), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 50/100.
Our analysis supports a neutral stance on DBV Technologies S.A.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign DBV Technologies S.A. a meaningful economic moat, scoring 37/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 12.9/20.
The strongest moat sources are margin superiority (12.9/20) and growth durability (11.7/20). GM 100% vs sector 43%, OM -2601% vs sector 1%. Rev growth 139%, 10yr history. These pillars form the core of DBV Technologies S.A.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (0/20) and financial resilience (5.2/20). ROE proxy -250.8% (sector -2.5%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Narrowing. ROIC has declined at ~273.6pp per year, and operating margins show fundamental deterioration. Investors should monitor these indicators closely — a sustained narrowing trend often precedes material downgrades in our moat assessment.
Key profit drivers include gross margins of 100% providing a solid profitability foundation, robust top-line growth of 139% expanding the revenue base. The margin cascade from 100% gross to -2601% operating to -2622.4% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 34th percentile.
The margin profile shows gross margins of 100%, operating margins of -2601%, net margins of -2622.4%. Return metrics include ROE of -250.8% and ROA of -120.0%. Relative to the Manufacturing sector, gross margins are 57.5 percentage points above the sector median of 43%, and ROE of -250.8% compares to a sector median of -2.5%.
The balance sheet reflects above-average leverage with D/E of 109%, revenue growth of 139%. The sector median D/E is 0%, putting DBV Technologies S.A. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Below-average quality (34th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.

DBV Technologies (NASDAQ:DBVT) stock price recently moved above its 50-day moving average, trading as high as $23.53 before settling at $21.61. This rise comes amidst several analysts issuing "Buy" or "Moderate Buy" ratings with target prices ranging up to $51.00. While a major shareholder reduced its position, institutional investors hold a significant portion of the stock.

DBV Technologies (NASDAQ:DBVT) has been downgraded from a "Hold" to a "Sell" rating by Wall Street Zen. Despite this, the stock still holds a "Moderate Buy" consensus rating from other analysts with an average price target of $35.38. The article also notes a significant insider sale by Bpifrance Epic and provides details on the company's price performance and institutional investor activity.

Cantor Fitzgerald has reiterated its Overweight rating on DBV Technologies (NASDAQ:DBVT), setting a price target of $48.00, significantly higher than its current price of $17.34. This positive outlook follows strong investor sentiment and the success of the company's Phase 3 VITESSE study for its Viaskin Peanut treatment. Despite not being currently profitable, the company holds more cash than debt and is expected to submit a Biologics License Application in the first half of 2026.

DBV Technologies S.A. (NASDAQ:DBVT) has received a consensus rating of "Moderate Buy" from ten brokerages, with an average 12-month price target of $35.38. This comes despite a recent insider sale by Bpifrance Epic, which reduced its stake by 19.46%. The company, focused on developing immunotherapies for allergic diseases using its Viaskin platform, has a market cap of approximately $720 million and its stock recently traded at $17.93.

DBV Technologies (NASDAQ:DBVT) gapped up before market open on Wednesday, with shares opening at $17.30 and last trading at $18.29. The company has a "Moderate Buy" consensus rating from analysts with a target price of $35.38, though major shareholder Bpifrance Epic recently sold over 1.2 million shares. Institutional investors own approximately 71.74% of the stock.
Above 50MA
37.18%
Net New Highs
+51081